Figure 4. Relative Risk (RR) of Estrogen Receptor (ER) Positive Breast Cancer in Chemoprevention Trials.

Figure 4. Relative Risk (RR) of Estrogen Receptor (ER) Positive Breast Cancer in Chemoprevention Trials

From: 3, Results

Cover of Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility
Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility [Internet].
Evidence Syntheses, No. 37.
Nelson HD, Huffman LH, Fu R, et al.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.